• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » addiction

Articles Tagged with ''addiction''

Research Update

Long-Term Patient Outcomes with Buprenorphine for Opioid Use Disorder

January 1, 2025
Peter J. Farago, MD.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Peter Farago, MD. Dr. Farago has no financial relationships with companies related to this material.

Researchers compare outcomes in patients who take buprenorphine for shorter and for longer. Their findings are revealing.


Read More
932166E5-62E0-43E0-A69E-50E2F9ECBE7F.jpeg
Expert Q&A

Managing Withdrawal From Multiple Substances

January 1, 2025
Darius Rastegar, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

F77DAC3D-1C61-47C4-8BAB-51075F046EEA.jpegDarius Rastegar, MD 

Associate professor of medicine, Johns Hopkins University School of Medicine, Baltimore, MD. 

Dr. Rastegar has no financial relationships with companies related to this material.

Substance use disorders are highly comorbid with one another and it is therefore common to have patients presenting for care withdrawing from multiple substances at one time. Here, Dr. Rastegar discusses how to assess patients with multiple withdrawal syndromes and how to treat them.


Read More
Clinical Update

Effective Management of Buprenorphine-Precipitated Opioid Withdrawal

January 1, 2025
Jaewon Lee, MD, MPH
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Jaewon Lee, MD, MPH. PGY-2, psychiatry resident, University of Rochester Medical Center, Rochester, NY. 

Dr. Lee has no financial relationships with companies related to this material.

Buprenorphine is a first-line treatment for opioid use disorder, however, given buprenorphine to a patient who still has opioids in their system can precipitate severe withdrawal. Careful assessment of withdrawal can minimize the risk, but despite our best efforts, precipitated withdrawal can still occur. In this article, we review what to do for our patients experiencing buprenorphine-precipitated opioid withdrawal.


Read More
TCPR-Oct2024_QA_NCapurso headshot.png
Clinical Update

A New Era for Buprenorphine

September 26, 2024
Noah Capurso, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

TCPR-Oct2024_QA_NCapurso headshot.pngNoah Capurso, MD, MHS.

Associate Professor of Psychiatry, Yale University, New Haven, CT; Editor-in-Chief, The Carlat Addiction Treatment Report.

Dr. Capurso has no financial relationships with companies related to this material.

A buprenorphine boot camp for all who need to know how to use it in the post-X-waiver age.


Read More
Clinical Update

Post X-Waiver Buprenorphine Prescribing

September 26, 2024
Noah Capurso, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Noah Capurso, MD, MHS. Associate Professor of Psychiatry, Yale University, New Haven, CT; Editor-in-Chief, The Carlat Addiction Treatment Report.

Dr. Capurso has no financial relationships with companies related to this material.

All clinicians need to know how to use buprenorphine under the DEAs new regulations. Meanwhile, the fentanyl crisis is changing how we use it. Noah Capurso shows us how to navigate these waters.


Read More
CarlatPsychEp1.png
CARLAT WEBINAR

Carlat Psychiatry News - Episode 3 - Lumateperone

August 1, 2024
Chris Aiken, MD, Greg Malzberg, MD, and Kellie Newsome, PMHNP

0.25 CME Credits. Highlights from this month include Lumateperone, Lavender, treatment resistant smoking, and Clonidine patches and Tourettes. A new meta analysis published in Psychiatry Research sheds light on a critical question.



Read More
Research Update

Daily Alcohol Intake and Risk for All-Cause Mortality

July 1, 2024
Eli Neustadter, MD, MSc.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Eli Neustadter, MD, MSc. Dr. Neustadter has no financial relationships with companies related to this material.

It was once thought that moderate alcohol intake was protective against cardiovascular disease. However, new research has revealed flaws in the methodology of these old studies and instead finds that even in moderation, alcohol does not have health benefits and can increase mortality at lower doses than once thought, particularly for women.


Read More
Research Update

Does Cannabis Legalization Increase the Risk of Driving-Related Injury?

July 1, 2024
Garrett Rossi, MD.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Garrett Rossi, MD. Dr. Rossi has no financial relationships with companies related to this material.

Everyone knows that it is dangerous to drive while under the influence of alcohol—but what about cannabis? This study adds to a growing body of evidence that cannabis can be hazardous to safety on the road, a particularly important message to get out to patients as legalization becomes increasingly common.


Read More
Clinical Update

Drug Testing and the Legal System

July 1, 2024
Paul A. Bryant, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Paul A. Bryant, MD, Assistant Professor of Psychiatry; Stephanie Eng, MD, Fellow in Forensic Psychiatry; Melissa Lavoie, MD, Fellow in Forensic Psychiatry. Yale University, New Haven, CT.

Drs. Bryant, Eng, and Lavoie have no financial relationships with companies related to this material.

Urine drug screens are frequently ordered for patients receiving addiction treatment. However, the results of these everyday tests can have outsized consequences for patients involved in the legal system. Here, we provide an overview of how drug testing is used in the legal system and how you can be an advocate for your patient.



Read More
Expert Q&A

Pregnancy, Addiction, and the Law

July 1, 2024
Elisabeth Johnson, PhD, FNP-BC, CARN-AP, LCAS
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

CATR_QA1_Johnson-Elisabeth_headshot.jpgElisabeth Johnson, PhD, FNP-BC, CARN-AP, LCAS.

Division Director, UNC Horizons; Clinical Assistant Professor,UNC-Chapel Hill, Carrboro, NC.

Dr. Johnson has no financial relationships with companies related to this material.

Dr. Johnson tells us all about Child Protective Services and how they work with pregnant patients who use substances. In this interview, she reviews the role of medical and mental health providers in the care of pregnant patients with addictive disorders and their legal obligations. She also provides tips for discussing these sensitive matters with your patients.


Read More
Previous 1 2 3 4 5 6 7 8 9 … 21 22 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2622607431.jpg
    General Psychiatry

    Should You Test MTHFR?

    MTHFR is a...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.